» Articles » PMID: 29335833

Regulation of Bone Metabolism by MicroRNAs

Overview
Publisher Current Science
Date 2018 Jan 17
PMID 29335833
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: The small non-coding microRNAs (miRNAs) have emerged as important post-transcriptional regulators of various physiological and pathological processes. The purpose of this article is to review the important recent advances on the role of miRNAs in bone remodeling and metabolic bone disorders.

Recent Findings: In a physiological context, miRNAs regulate bone formation and bone resorption, thereby contributing to the maintenance of bone homeostasis. Under pathological conditions, an aberrant miRNA signaling contributes to the onset and progression of skeletal disorders, such as osteoporosis. Furthermore, miRNAs can be secreted to circulation and have clinical potential as non-invasive biomarkers. In a therapeutic setting, miRNA delivery or antagonism has been reported to affect several diseases under pre-clinical conditions thereby emerging as novel pharmacological tools. miRNAs are key regulators of bone remodeling in health and disease. The future perspectives in the field include the role of secreted miRNAs in cell-cell communication in the bone environment. Furthermore, the clinical potential of using miRNAs as diagnostic tools and therapeutic targets to treat metabolic bone diseases provides an attractive future direction.

Citing Articles

miR-374-5p inhibits osteogenesis by targeting PTEN/PI3K/AKT signaling pathway.

Long G, Liu F, Cheng H, Guo J, Wang P, Luo Y J Orthop Surg Res. 2025; 20(1):283.

PMID: 40087681 DOI: 10.1186/s13018-025-05670-x.


MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model.

Morakotsriwan M, Chanamuangkon T, Vacharaksa A, Limlawan P Front Dent Med. 2025; 5:1477274.

PMID: 39917666 PMC: 11797932. DOI: 10.3389/fdmed.2024.1477274.


Regulatory cellular and molecular networks in the bone microenvironment during aging.

Zhang L, Wang Z, Zhang Y, Ji R, Li Z, Zou J Life Med. 2025; 3(3):lnae019.

PMID: 39871887 PMC: 11749081. DOI: 10.1093/lifemedi/lnae019.


The Regulatory Role of miRNAs in Zebrafish Fin Regeneration.

Fan J, Liu X, Duan Z, Zhao H, Chang Z, Li L Int J Mol Sci. 2024; 25(19).

PMID: 39408869 PMC: 11477159. DOI: 10.3390/ijms251910542.


Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.

Zhang R, Mu X, Liu D, Chen C, Meng B, Qu Y J Nanobiotechnology. 2024; 22(1):580.

PMID: 39304875 PMC: 11414301. DOI: 10.1186/s12951-024-02829-2.


References
1.
Seeliger C, Karpinski K, Haug A, Vester H, Schmitt A, Bauer J . Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 2014; 29(8):1718-28. DOI: 10.1002/jbmr.2175. View

2.
Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

3.
Chen C, Ridzon D, Broomer A, Zhou Z, Lee D, Nguyen J . Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179. PMC: 1292995. DOI: 10.1093/nar/gni178. View

4.
Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D . miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015; 12(3):343-53. PMC: 4615895. DOI: 10.1080/15476286.2015.1017205. View

5.
Harvey N, Dennison E, Cooper C . Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010; 6(2):99-105. DOI: 10.1038/nrrheum.2009.260. View